Sparrow Pharmaceuticals
Jamie has 20 years of experience as a Regulatory Affairs and Quality Assurance professional in the pharmaceutical/biotechnology industry across a wide variety of therapeutic areas, including Neurology, Cardiology, Endocrinology, Reproductive Health, and Nephrology. She specializes in bringing innovative treatments to patients with serious and rare diseases to address unmet medical needs. Throughout her career, she has provided strategic advice in the development or commercialization 20 products at Akcea Therapeutics, Alexion Pharmaceuticals, Genzyme Corporation, EMD Serono, Inc, and Repligen Corporation.
Jamie earned a Doctor of Pharmacy degree from the Bouvé College of Health Sciences at Northeastern University. In her spare time, Jamie enjoys spending time with her family, skiing and mountain biking, and community service.
This person is not in any offices
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.